Search This Blog

Wednesday, November 6, 2019

Aerie Pharma down 15% after hours as product sales lag

Aerie Pharmaceuticals (NASDAQ:AERI) Q3 results:
Product sales: $18.5M (+153.4%).
Net loss: ($49.4M) (+42.2%); loss/share: ($1.09).
2019 guidance: Revenues: $61M – 66M from $70M – 80M.
Previously: Aerie Pharmaceuticals EPS misses by $0.06, beats on revenue (Nov. 6)
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)